Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2020 Jun 23;S1569-1993(20)30730-X. doi: 10.1016/j.jcf.2020.06.001.
Document
Link
Keywords
Clinical trial [3]
Phase 3 [4]
Phe508del-CFTR [5]
Date
Tuesday, June 23, 2020
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [6]